Ocrelizumab

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1395 publications

Pregnancy Exposure to Anti-CD20 Monoclonal Antibodies in Patients With Multiple Sclerosis: Results From an Italian Multicenter Registry Study.

Pregnancy Exposure to Anti-CD20 Monoclonal Antibodies in Patients With Multiple Sclerosis: Results From an Italian Multicenter Registry Study.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: August 28, 2026

FCGR3A Polymorphism Controls B-Cell Repopulation Kinetics in People With Multiple Sclerosis Treated With Ocrelizumab.

FCGR3A Polymorphism Controls B-Cell Repopulation Kinetics in People With Multiple Sclerosis Treated With Ocrelizumab.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: August 11, 2026

Natalizumab and Tyruko (natalizumab biosimilar) for treating highly active relapsing-remitting multiple sclerosis after at least one disease-modifying therapy: a systematic review and economic model.

Natalizumab and Tyruko (natalizumab biosimilar) for treating highly active relapsing-remitting multiple sclerosis after at least one disease-modifying therapy: a systematic review and economic model.

Journal: Health technology assessment (Winchester, England)

Published: August 11, 2026

Severe Nonhepatic Hyperammonemia Associated With Ureaplasma parvum and Mycoplasma hominis Infection in a Dually Immunosuppressed Woman Presenting As Suspected Peritoneal Carcinomatosis.

Severe Nonhepatic Hyperammonemia Associated With Ureaplasma parvum and Mycoplasma hominis Infection in a Dually Immunosuppressed Woman Presenting As Suspected Peritoneal Carcinomatosis.

Journal: Cureus

Published: August 05, 2026

Borrelia miyamotoi meningoradiculitis complicating ocrelizumab treatment for multiple sclerosis: A report of three cases.

Borrelia miyamotoi meningoradiculitis complicating ocrelizumab treatment for multiple sclerosis: A report of three cases.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: August 04, 2026

Do All Stable Patients on Ocrelizumab Need Annual MRI?

Do All Stable Patients on Ocrelizumab Need Annual MRI?

Journal: Neurology

Published: July 29, 2026

Value of Annual MRI Monitoring in Patients With Multiple Sclerosis Treated With Ocrelizumab: A Number Needed to Scan Analysis.

Value of Annual MRI Monitoring in Patients With Multiple Sclerosis Treated With Ocrelizumab: A Number Needed to Scan Analysis.

Journal: Neurology

Published: July 29, 2026

Ocrelizumab-induced colitis acutely managed with ciclosporin.

Ocrelizumab-induced colitis acutely managed with ciclosporin.

Journal: BMJ case reports

Published: July 22, 2026

Comparative effectiveness of rituximab versus ocrelizumab in relapsing multiple sclerosis on clinical relapses and radiological outcomes in British Columbia, Canada.

Comparative effectiveness of rituximab versus ocrelizumab in relapsing multiple sclerosis on clinical relapses and radiological outcomes in British Columbia, Canada.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: July 03, 2026

Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis.

Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis.

Journal: The New England journal of medicine

Published: July 01, 2026

Longitudinal magnetic resonance spectroscopy study of metabolite changes over 2 years in relapsing and primary progressive multiple sclerosis treated with ocrelizumab.

Longitudinal magnetic resonance spectroscopy study of metabolite changes over 2 years in relapsing and primary progressive multiple sclerosis treated with ocrelizumab.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: June 30, 2026

From options to decisions: an innovative model for treatment sequencing in relapsing-remitting multiple sclerosis.

From options to decisions: an innovative model for treatment sequencing in relapsing-remitting multiple sclerosis.

Journal: Journal of medical economics

Published: June 24, 2026

Showing 1-12 of 1,395

Last Updated: 09/26/2026